Submitted by Anonymous (not verified) on 26 September 2023 - 11:12
Human medicines European public assessment report (EPAR): Abrysvo, Respiratory syncytial virus vaccine (bivalent, recombinant), Respiratory Syncytial Virus Infections, Date of authorisation: 23/08/2023, Status: Authorised
Source: